Omentoplasty Versus Tube Drainage for Residual Cavity Management in Complicated Hepatic Cystic Echinococcosis
1 other identifier
interventional
60
1 country
1
Brief Summary
This prospective comparative study evaluated two surgical techniques for residual cavity management following conservative surgery for complicated hepatic cystic echinococcosis. Patients undergoing surgery were managed with either omentoplasty or tube drainage. The study aimed to compare postoperative outcomes between the two techniques, with particular emphasis on postoperative complications and residual cavity-related complications. Long-term follow-up was also performed to assess recurrence and other clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedFirst Submitted
Initial submission to the registry
August 26, 2026
CompletedFirst Posted
Study publicly available on registry
August 28, 2026
CompletedAugust 28, 2026
August 1, 2026
1.3 years
August 26, 2026
August 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Residual Cavity-Related Complications
Incidence of postoperative complications related to the residual hepatic cyst cavity, including residual cavity infection, abscess formation, or other cavity-related complications, compared between the omentoplasty and tube drainage groups.
Up to 30 days after surgery
Secondary Outcomes (5)
Postoperative Bile Leakage
Up to 30 days after surgery
Surgical Site Infection
Up to 30 days after surgery
Overall Postoperative Complications
Up to 30 days after surgery
Operative Time
During surgery
Recurrence of Hepatic Cystic Echinococcosis
Up to at least 60 months after surgery
Study Arms (2)
Omentoplasty Group
EXPERIMENTALParticipants underwent conservative surgery for complicated hepatic cystic echinococcosis followed by omentoplasty for residual cavity management.
Tube Drainage Group
ACTIVE COMPARATORParticipants underwent conservative surgery for complicated hepatic cystic echinococcosis followed by external tube drainage for residual cavity management.
Interventions
After conservative surgery for complicated hepatic cystic echinococcosis, the residual cavity was obliterated using a pedicled omental flap (omentoplasty) to reduce dead space and cavity-related complications.
After conservative surgery for complicated hepatic cystic echinococcosis, an external tube drain was placed into the residual cavity for postoperative drainage and monitoring.
Eligibility Criteria
You may qualify if:
- Age 18-80 years.
- Complicated hepatic cystic echinococcosis requiring surgical treatment.
- Cyst diameter ≥8 cm.
- Cysts located in hepatic segments IV, V, VI, VII, or VIII.
- WHO-IWGE CE2 or CE3b cyst stage.
- Presence of at least one complication or high-risk feature, including rupture, adjacent organ involvement, cholangitis, biliary communication, or cyst infection.
- ASA physical status ≤III.
You may not qualify if:
- WHO-IWGE CE1 or CE3a cyst stage.
- Cysts located in hepatic segments I, II, or III.
- Extensive multiple hepatic cysts.
- Previous surgery for hepatic cystic echinococcosis.
- Malignancy.
- Pregnancy.
- ASA physical status \>III.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atatürk University Faculty of Medicine
Erzurum, Erzurum, 25240, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
August 26, 2026
First Posted
August 28, 2026
Study Start
March 10, 2020
Primary Completion
June 10, 2021
Study Completion
March 10, 2026
Last Updated
August 28, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to patient confidentiality and ethical considerations. Aggregate study results will be reported in the planned scientific publication.